Methylation and gene silencing of the ras-related GTPase gene in lung and breast cancers

Makoto Suzuki, Hisayuki Shigematsu, David S. Shames, Noriaki Sunaga, Takao Takahashi, Narayan Shivapurkar, Toshihiko Iizasa, John D. Minna, Takehiko Fujisawa, Adi F. Gazdar

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: RRAD, a small Ras-related GTPase, is highly expressed in human skeletal muscle, lung, and heart. Although loss of expression of RRAD in breast cancer cells has been reported and it may act as an oncogene, the mechanism of silencing is unknown. Methods: We examined (1) mRNA expression of RRAD in lung and breast cancer cell lines using RT-PCR and (2) methylation status of lung and breast cancers. Results: Loss of RRAD expression was found in 14 of 20 (70%) NSCLC cell lines, 11 of 11 (100%) SCLC cell lines, and 8 of 10 (80%) breast cancer cell lines; expression was not affected in normal bronchial and mammary epithelial cells. Treatment of 23 expression-negative cell lines with a demethylating agent restored expression in all cases. We developed a methylation-specific assay from the analysis of bisulfite sequencing of the 5′ region of RRAD in expression-negative and positive cell lines, which resulted in good concordance between methylation and expression. Primary lung and breast cancers showed hypermethylation in 89 of 214 (42%) and 39 of 63 (62%) cases, respectively. RRAD hypermethylation correlated with smoking history and poorer prognosis in lung adenocarcinomas. Conclusions: We conclude that epigenetic silencing of RRAD is a frequent event in lung and breast cancers, and analysis of it may provide novel opportunities for prognosis and therapy of these cancers.

Original languageEnglish (US)
Pages (from-to)1397-1404
Number of pages8
JournalAnnals of Surgical Oncology
Volume14
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

Monomeric GTP-Binding Proteins
Gene Silencing
Methylation
Lung Neoplasms
Breast Neoplasms
Cell Line
Genes
Oncogenes
Epigenomics
Skeletal Muscle
Breast
Smoking
History
Epithelial Cells
Polymerase Chain Reaction
Lung
Messenger RNA
Neoplasms

Keywords

  • Breast cancer
  • Lung cancer
  • Methylation
  • RRAD

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Methylation and gene silencing of the ras-related GTPase gene in lung and breast cancers. / Suzuki, Makoto; Shigematsu, Hisayuki; Shames, David S.; Sunaga, Noriaki; Takahashi, Takao; Shivapurkar, Narayan; Iizasa, Toshihiko; Minna, John D.; Fujisawa, Takehiko; Gazdar, Adi F.

In: Annals of Surgical Oncology, Vol. 14, No. 4, 04.2007, p. 1397-1404.

Research output: Contribution to journalArticle

Suzuki, M, Shigematsu, H, Shames, DS, Sunaga, N, Takahashi, T, Shivapurkar, N, Iizasa, T, Minna, JD, Fujisawa, T & Gazdar, AF 2007, 'Methylation and gene silencing of the ras-related GTPase gene in lung and breast cancers', Annals of Surgical Oncology, vol. 14, no. 4, pp. 1397-1404. https://doi.org/10.1245/s10434-006-9089-6
Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N et al. Methylation and gene silencing of the ras-related GTPase gene in lung and breast cancers. Annals of Surgical Oncology. 2007 Apr;14(4):1397-1404. https://doi.org/10.1245/s10434-006-9089-6
Suzuki, Makoto ; Shigematsu, Hisayuki ; Shames, David S. ; Sunaga, Noriaki ; Takahashi, Takao ; Shivapurkar, Narayan ; Iizasa, Toshihiko ; Minna, John D. ; Fujisawa, Takehiko ; Gazdar, Adi F. / Methylation and gene silencing of the ras-related GTPase gene in lung and breast cancers. In: Annals of Surgical Oncology. 2007 ; Vol. 14, No. 4. pp. 1397-1404.
@article{1dcbe64133574ee7b3e2a84f40a0d25a,
title = "Methylation and gene silencing of the ras-related GTPase gene in lung and breast cancers",
abstract = "Background: RRAD, a small Ras-related GTPase, is highly expressed in human skeletal muscle, lung, and heart. Although loss of expression of RRAD in breast cancer cells has been reported and it may act as an oncogene, the mechanism of silencing is unknown. Methods: We examined (1) mRNA expression of RRAD in lung and breast cancer cell lines using RT-PCR and (2) methylation status of lung and breast cancers. Results: Loss of RRAD expression was found in 14 of 20 (70{\%}) NSCLC cell lines, 11 of 11 (100{\%}) SCLC cell lines, and 8 of 10 (80{\%}) breast cancer cell lines; expression was not affected in normal bronchial and mammary epithelial cells. Treatment of 23 expression-negative cell lines with a demethylating agent restored expression in all cases. We developed a methylation-specific assay from the analysis of bisulfite sequencing of the 5′ region of RRAD in expression-negative and positive cell lines, which resulted in good concordance between methylation and expression. Primary lung and breast cancers showed hypermethylation in 89 of 214 (42{\%}) and 39 of 63 (62{\%}) cases, respectively. RRAD hypermethylation correlated with smoking history and poorer prognosis in lung adenocarcinomas. Conclusions: We conclude that epigenetic silencing of RRAD is a frequent event in lung and breast cancers, and analysis of it may provide novel opportunities for prognosis and therapy of these cancers.",
keywords = "Breast cancer, Lung cancer, Methylation, RRAD",
author = "Makoto Suzuki and Hisayuki Shigematsu and Shames, {David S.} and Noriaki Sunaga and Takao Takahashi and Narayan Shivapurkar and Toshihiko Iizasa and Minna, {John D.} and Takehiko Fujisawa and Gazdar, {Adi F.}",
year = "2007",
month = "4",
doi = "10.1245/s10434-006-9089-6",
language = "English (US)",
volume = "14",
pages = "1397--1404",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Methylation and gene silencing of the ras-related GTPase gene in lung and breast cancers

AU - Suzuki, Makoto

AU - Shigematsu, Hisayuki

AU - Shames, David S.

AU - Sunaga, Noriaki

AU - Takahashi, Takao

AU - Shivapurkar, Narayan

AU - Iizasa, Toshihiko

AU - Minna, John D.

AU - Fujisawa, Takehiko

AU - Gazdar, Adi F.

PY - 2007/4

Y1 - 2007/4

N2 - Background: RRAD, a small Ras-related GTPase, is highly expressed in human skeletal muscle, lung, and heart. Although loss of expression of RRAD in breast cancer cells has been reported and it may act as an oncogene, the mechanism of silencing is unknown. Methods: We examined (1) mRNA expression of RRAD in lung and breast cancer cell lines using RT-PCR and (2) methylation status of lung and breast cancers. Results: Loss of RRAD expression was found in 14 of 20 (70%) NSCLC cell lines, 11 of 11 (100%) SCLC cell lines, and 8 of 10 (80%) breast cancer cell lines; expression was not affected in normal bronchial and mammary epithelial cells. Treatment of 23 expression-negative cell lines with a demethylating agent restored expression in all cases. We developed a methylation-specific assay from the analysis of bisulfite sequencing of the 5′ region of RRAD in expression-negative and positive cell lines, which resulted in good concordance between methylation and expression. Primary lung and breast cancers showed hypermethylation in 89 of 214 (42%) and 39 of 63 (62%) cases, respectively. RRAD hypermethylation correlated with smoking history and poorer prognosis in lung adenocarcinomas. Conclusions: We conclude that epigenetic silencing of RRAD is a frequent event in lung and breast cancers, and analysis of it may provide novel opportunities for prognosis and therapy of these cancers.

AB - Background: RRAD, a small Ras-related GTPase, is highly expressed in human skeletal muscle, lung, and heart. Although loss of expression of RRAD in breast cancer cells has been reported and it may act as an oncogene, the mechanism of silencing is unknown. Methods: We examined (1) mRNA expression of RRAD in lung and breast cancer cell lines using RT-PCR and (2) methylation status of lung and breast cancers. Results: Loss of RRAD expression was found in 14 of 20 (70%) NSCLC cell lines, 11 of 11 (100%) SCLC cell lines, and 8 of 10 (80%) breast cancer cell lines; expression was not affected in normal bronchial and mammary epithelial cells. Treatment of 23 expression-negative cell lines with a demethylating agent restored expression in all cases. We developed a methylation-specific assay from the analysis of bisulfite sequencing of the 5′ region of RRAD in expression-negative and positive cell lines, which resulted in good concordance between methylation and expression. Primary lung and breast cancers showed hypermethylation in 89 of 214 (42%) and 39 of 63 (62%) cases, respectively. RRAD hypermethylation correlated with smoking history and poorer prognosis in lung adenocarcinomas. Conclusions: We conclude that epigenetic silencing of RRAD is a frequent event in lung and breast cancers, and analysis of it may provide novel opportunities for prognosis and therapy of these cancers.

KW - Breast cancer

KW - Lung cancer

KW - Methylation

KW - RRAD

UR - http://www.scopus.com/inward/record.url?scp=34047237085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047237085&partnerID=8YFLogxK

U2 - 10.1245/s10434-006-9089-6

DO - 10.1245/s10434-006-9089-6

M3 - Article

VL - 14

SP - 1397

EP - 1404

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 4

ER -